Published in Mol Biol Cell on July 01, 2001
More forks on the road to replication stress recovery. J Mol Cell Biol (2011) 1.64
The 32-kilodalton subunit of replication protein A interacts with menin, the product of the MEN1 tumor suppressor gene. Mol Cell Biol (2003) 1.48
Replication fork stalling in WRN-deficient cells is overcome by prompt activation of a MUS81-dependent pathway. J Cell Biol (2008) 1.31
Human chromosomes 9, 12, and 15 contain the nucleation sites of stress-induced nuclear bodies. Mol Biol Cell (2002) 1.23
DNA replication: a complex matter. EMBO Rep (2003) 1.15
Cell cycle-dependent dynamic association of cyclin/Cdk complexes with human DNA replication proteins. EMBO J (2002) 1.03
Multiple roles for kinases in DNA replication. EMBO Rep (2003) 0.97
Antioxidant enzymes reduce DNA damage and early activation of valvular interstitial cells in aortic valve sclerosis. Arterioscler Thromb Vasc Biol (2012) 0.94
Phosphorylation of human DNA ligase I regulates its interaction with replication factor C and its participation in DNA replication and DNA repair. Mol Cell Biol (2009) 0.91
Uracil-DNA glycosylase expression determines human lung cancer cell sensitivity to pemetrexed. Mol Cancer Ther (2013) 0.84
Uracil DNA glycosylase (UNG) loss enhances DNA double strand break formation in human cancer cells exposed to pemetrexed. Cell Death Dis (2014) 0.80
Molecular mechanisms of etoposide. EXCLI J (2015) 0.75
Common Chemical Inductors of Replication Stress: Focus on Cell-Based Studies. Biomolecules (2017) 0.75
Collision of Trapped Topoisomerase 2 with Transcription and Replication: Generation and Repair of DNA Double-Strand Breaks with 5' Adducts. Genes (Basel) (2016) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
The DNA damage response: putting checkpoints in perspective. Nature (2000) 19.07
Replication protein A: a heterotrimeric, single-stranded DNA-binding protein required for eukaryotic DNA metabolism. Annu Rev Biochem (1997) 9.83
A Mec1- and Rad53-dependent checkpoint controls late-firing origins of DNA replication. Nature (1998) 6.47
Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1. Science (1997) 5.05
Dynamics of DNA replication factories in living cells. J Cell Biol (2000) 4.93
Activation of Rad53 kinase in response to DNA damage and its effect in modulating phosphorylation of the lagging strand DNA polymerase. EMBO J (1999) 4.64
Dynamic organization of DNA replication in mammalian cell nuclei: spatially and temporally defined replication of chromosome-specific alpha-satellite DNA sequences. J Cell Biol (1992) 4.39
Nuclear foci of mammalian recombination proteins are located at single-stranded DNA regions formed after DNA damage. Proc Natl Acad Sci U S A (1999) 3.68
The puzzle of PCNA's many partners. Bioessays (2000) 3.54
Reversal of terminal differentiation and control of DNA replication: cyclin A and Cdk2 specifically localize at subnuclear sites of DNA replication. Cell (1993) 3.42
Visualization of replication factories attached to nucleoskeleton. Cell (1993) 3.36
Replication-mediated DNA damage by camptothecin induces phosphorylation of RPA by DNA-dependent protein kinase and dissociates RPA:DNA-PK complexes. EMBO J (1999) 3.13
Double-strand break repair in yeast requires both leading and lagging strand DNA polymerases. Cell (1999) 2.89
Mcm2, but not RPA, is a component of the mammalian early G1-phase prereplication complex. J Cell Biol (1999) 2.43
Rad51 accumulation at sites of DNA damage and in postreplicative chromatin. J Cell Biol (2000) 2.22
DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene (1999) 2.10
Temporally coordinated assembly and disassembly of replication factories in the absence of DNA synthesis. Nat Cell Biol (2000) 2.02
The ionizing radiation-induced replication protein A phosphorylation response differs between ataxia telangiectasia and normal human cells. Mol Cell Biol (1993) 2.01
Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells. Cancer Res (1989) 1.94
Cell death induced by topoisomerase-targeted drugs: more questions than answers. Biochim Biophys Acta (1998) 1.83
The N-terminal domain of human DNA ligase I contains the nuclear localization signal and directs the enzyme to sites of DNA replication. EMBO J (1995) 1.59
p21Cip1/Waf1 disrupts the recruitment of human Fen1 by proliferating-cell nuclear antigen into the DNA replication complex. Proc Natl Acad Sci U S A (1996) 1.53
Replication factories and nuclear bodies: the ultrastructural characterization of replication sites during the cell cycle. J Cell Sci (1994) 1.52
Structural and functional analysis of poly(ADP ribose) polymerase: an immunological study. Biochim Biophys Acta (1988) 1.42
The replication factory targeting sequence/PCNA-binding site is required in G(1) to control the phosphorylation status of DNA ligase I. EMBO J (1999) 1.14
Who binds wins: Competition for PCNA rings out cell-cycle changes. Trends Cell Biol (1997) 1.03
Late induction of human DNA ligase I after UV-C irradiation. Nucleic Acids Res (1995) 0.89
The effect of the chemotherapeutic drug VP-16 on poly(ADP-ribosylation) in apoptotic HeLa cells. Carcinogenesis (1993) 0.87
Detection of poly(ADP-ribose) polymerase and its apoptosis-specific fragment by a nonisotopic activity-western blot technique. Anal Biochem (1995) 0.87
Single-lead VDD pacing system. Pacing Clin Electrophysiol (1990) 5.21
HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science (1997) 4.58
Retracted Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation (2002) 4.30
A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. Gene (1992) 3.48
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia (2000) 3.32
An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery (1988) 3.27
Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment. Exp Hematol (1997) 2.92
Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients. Science (1995) 2.79
Start sites of bidirectional DNA synthesis at the human lamin B2 origin. Science (2000) 2.72
Transcript imaging of the development of human T helper cells using oligonucleotide arrays. Nat Genet (2000) 2.71
Fine mapping of a replication origin of human DNA. Proc Natl Acad Sci U S A (1994) 2.44
cDNA cloning of human hnRNP protein A1 reveals the existence of multiple mRNA isoforms. Nucleic Acids Res (1988) 2.32
Nucleo-cytoplasmic distribution of human hnRNP proteins: a search for the targeting domains in hnRNP A1. J Cell Sci (1995) 2.27
Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo. J Exp Med (1991) 2.11
Double labelling of subcellular structures with organelle-targeted GFP mutants in vivo. Curr Biol (1996) 2.10
hnRNP A1 selectively interacts through its Gly-rich domain with different RNA-binding proteins. J Mol Biol (1996) 2.04
Calcitriol and calcium carbonate therapy in early chronic renal failure. Nephrol Dial Transplant (1994) 2.03
Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial polymerase gamma mutations. Neurology (2005) 2.01
Randomized controlled trial of single-agent paclitaxel versus cyclophosphamide, doxorubicin, and cisplatin in patients with recurrent ovarian cancer who responded to first-line platinum-based regimens. J Clin Oncol (2002) 2.00
Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1. Nat Genet (2001) 2.00
Early surgery for acute gallstone pancreatitis: evaluation of a systematic approach. Surgery (1978) 1.98
Mammalian single-stranded DNA binding protein UP I is derived from the hnRNP core protein A1. EMBO J (1986) 1.94
Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study. Intensive Care Med (1998) 1.90
T cell assays and MIATA: the essential minimum for maximum impact. Immunity (2012) 1.74
Recombinant hnRNP protein A1 and its N-terminal domain show preferential affinity for oligodeoxynucleotides homologous to intron/exon acceptor sites. Nucleic Acids Res (1990) 1.72
Stress-induced nuclear bodies are sites of accumulation of pre-mRNA processing factors. Mol Biol Cell (2001) 1.72
Piggy-back versus conventional technique in liver transplantation: report of a randomized trial. Transpl Int (1997) 1.70
Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease. J Clin Endocrinol Metab (1998) 1.68
Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J Biol Chem (2001) 1.67
Reversible immortalization of human myogenic cells by site-specific excision of a retrovirally transferred oncogene. Hum Gene Ther (1999) 1.66
Alternative splicing in the human gene for the core protein A1 generates another hnRNP protein. EMBO J (1990) 1.65
The roles of heterogeneous nuclear ribonucleoproteins (hnRNP) in RNA metabolism. Bioessays (1996) 1.63
Non-length-dependent small fibre neuropathy. Confocal microscopy study of the corneal innervation. J Neurol Neurosurg Psychiatry (2010) 1.62
Orthologous myosin isoforms and scaling of shortening velocity with body size in mouse, rat, rabbit and human muscles. J Physiol (2003) 1.60
Safety of retroviral gene marking with a truncated NGF receptor. Nat Med (2003) 1.60
The actin cytoskeleton response to oxidants: from small heat shock protein phosphorylation to changes in the redox state of actin itself. Free Radic Biol Med (2001) 1.60
The N-terminal domain of human DNA ligase I contains the nuclear localization signal and directs the enzyme to sites of DNA replication. EMBO J (1995) 1.59
Cyclin dependent kinase inhibitors and dominant negative cyclin dependent kinase 4 and 6 promote survival of NGF-deprived sympathetic neurons. J Neurosci (1997) 1.54
S-glutathionylation: from redox regulation of protein functions to human diseases. J Cell Mol Med (2004) 1.53
Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study. Gynecol Oncol (2001) 1.51
A novel hnRNP protein (HAP/SAF-B) enters a subset of hnRNP complexes and relocates in nuclear granules in response to heat shock. J Cell Sci (1999) 1.50
The importance of erythroid expansion in determining the extent of apoptosis in erythroid precursors in patients with beta-thalassemia major. Blood (2000) 1.49
Aldosterone inhibition limits collagen synthesis and progressive left ventricular enlargement after anterior myocardial infarction. Am Heart J (2001) 1.47
Excellent safety and tolerability of the human immunodeficiency virus type 1 pGA2/JS2 plasmid DNA priming vector vaccine in HIV type 1 uninfected adults. AIDS Res Hum Retroviruses (2006) 1.47
Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. Blood (1994) 1.45
Clonal analysis of stably transduced human epidermal stem cells in culture. Proc Natl Acad Sci U S A (1996) 1.44
Bone loss determined by quantitative ultrasonometry correlates inversely with disease activity in patients with endogenous glucocorticoid excess due to adrenal mass. Eur J Endocrinol (2001) 1.44
Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external ophthalmoplegia (PEO). Neurology (2003) 1.43
High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies. J Clin Invest (1998) 1.43
Different dysregulations in adrenal steroid biosynthesis as a prevalent cause of hyperandrogenism in women from southern Italy. Fertil Steril (1997) 1.40
Targeting aequorin and green fluorescent protein to intracellular organelles. Gene (1996) 1.39
Early apoptosis plays an important role in the healing mechanism of cutaneous basal cell carcinomas after photodynamic therapy. Br J Dermatol (2003) 1.39
Epithelioid leiomyoma of the breast with granular cell change: a case report. Hum Pathol (1993) 1.38
Monoethylglycinexylidide production as a measure in predicting hepatic histology. Ital J Gastroenterol (1994) 1.38
Regulation of base balance in bicarbonate hemofiltration. Int J Artif Organs (1994) 1.38
Performance of serum-supplemented and serum-free media in IFNgamma Elispot Assays for human T cells. Cancer Immunol Immunother (2009) 1.36
Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas. Cancer Res (1998) 1.36
CD8+ T cell-mediated suppressive activity inhibits HIV-1 after virus entry with kinetics indicating effects on virus gene expression. Proc Natl Acad Sci U S A (2000) 1.35
Reversible S-glutathionylation of Cys 374 regulates actin filament formation by inducing structural changes in the actin molecule. Free Radic Biol Med (2003) 1.34
Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment. J Neurol Neurosurg Psychiatry (2006) 1.34
Chick-embryo DNA polymerase gamma. Identity of gamma-polymerases purified from nuclei and mitochondria. Eur J Biochem (1977) 1.34
Cell cycle modulation of protein-DNA interactions at a human replication origin. EMBO J (1998) 1.32
Neonatal screening for hearing disorders in infants at risk: incidence, risk factors, and follow-up. Pediatrics (1999) 1.32
Gastric smooth muscle tumors: diagnostic dilemmas and factors affecting outcome. World J Surg (1996) 1.32
Single stranded DNA binding proteins derive from hnRNP proteins by proteolysis in mammalian cells. Nucleic Acids Res (1985) 1.32
The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity. Exp Cell Res (1998) 1.32
Large-scale purification of hnRNP proteins from HeLa cells by affinity chromatography on ssDNA-cellulose. Eur J Biochem (1987) 1.30
In vivo protein-DNA interactions at human DNA replication origin. Proc Natl Acad Sci U S A (1996) 1.27
Formation of a matter-wave bright soliton. Science (2002) 1.27
Methionine oxidation as a major cause of the functional impairment of oxidized actin. Free Radic Biol Med (2002) 1.27
Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response. Proc Natl Acad Sci U S A (1999) 1.27
Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application. Curr Drug Metab (2007) 1.26
Specific contributions of various muscle fibre types to human muscle performance: an in vitro study. J Electromyogr Kinesiol (1999) 1.26
Structure and dynamics of hnRNP-labelled nuclear bodies induced by stress treatments. J Cell Sci (2000) 1.25
Immunosuppressive effect of cyclosporin A on resistance to systemic infection with Candida albicans. J Med Microbiol (1989) 1.25
Enzymatically active forms of reverse transcriptase of the human immunodeficiency virus. AIDS Res Hum Retroviruses (1988) 1.24
Stimulation of 45Ca efflux from smooth muscle cells by metabolic inhibition and high K depolarization. Pflugers Arch (1975) 1.24
Further evidence of the validity of risk group definition in differentiated thyroid carcinoma. Surgery (1985) 1.23
Mammalian single-stranded DNA binding proteins and heterogeneous nuclear RNA proteins have common antigenic determinants. Nucleic Acids Res (1985) 1.23
Differing ADP release rates from myosin heavy chain isoforms define the shortening velocity of skeletal muscle fibers. J Biol Chem (2001) 1.23
Left atrial size is the major predictor of cardiac death and overall clinical outcome in patients with dilated cardiomyopathy: a long-term follow-up study. Clin Cardiol (1997) 1.23
Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma. Ann Oncol (2004) 1.22
Mental, physical and functional status in primary care attenders. Int J Psychiatry Med (1999) 1.21
Functional characterization of the T4 DNA ligase: a new insight into the mechanism of action. Nucleic Acids Res (1997) 1.20
Actin carbonylation: from a simple marker of protein oxidation to relevant signs of severe functional impairment. Free Radic Biol Med (2001) 1.20
Oligoclonal CD8 lymphocytes from persons with asymptomatic human immunodeficiency virus (HIV) type 1 infection inhibit HIV-1 replication. J Infect Dis (1995) 1.19
Nerve growth factor activates Thy-1 and neurofilament gene transcription in rat PC12 cells. EMBO J (1986) 1.19
The specific binding of nuclear protein(s) to the cAMP responsive element (CRE) sequence (TGACGTCA) is reduced by the misincorporation of U and increased by the deamination of C. Nucleic Acids Res (1990) 1.16
alpha2-chimaerin, a Cdc42/Rac1 regulator, is selectively expressed in the rat embryonic nervous system and is involved in neuritogenesis in N1E-115 neuroblastoma cells. J Neurosci (2001) 1.15
The replication factory targeting sequence/PCNA-binding site is required in G(1) to control the phosphorylation status of DNA ligase I. EMBO J (1999) 1.14
Poly(ADP-ribose) glycohydrolase is present and active in mammalian cells as a 110-kDa protein. Exp Cell Res (1999) 1.14
Motor recovery after stroke. Morphological and functional brain alterations. Brain (1996) 1.12
Identification of Culicoides obsoletus (Diptera: Ceratopogonidae) as a vector of bluetongue virus in central Italy. Vet Rec (2005) 1.11
Group B Streptococcus induces apoptosis in macrophages. J Immunol (2000) 1.11
Controlled plasma exchange trial in acute renal failure due to multiple myeloma. Kidney Int (1988) 1.11
In vivo genetic variability of the human immunodeficiency virus type 2 V3 region. J Virol (1992) 1.11